Aptevo Therapeutics Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Advisory Agreements (1 contract)
- Collaboration Agreements (6)
- Services Agreements (2)
- Supply Agreements (1)
- Financial Advisory Agreement, dated as of November 9, 2023, between A.G.P./Alliance Global Partners and the Company (Filed With SEC on November 9, 2023)
- Amendment No. 4 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Emergent Product Development... (Filed With SEC on August 14, 2020)
- Amendment No. 3 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Emergent Product Development... (Filed With SEC on August 14, 2020)
- Amendment No. 2 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Trubion Pharmaceuticals, Inc.... (Filed With SEC on August 14, 2020)
- Amendment No. 1 to the Collaboration and License Agreement dated as of December 19, 2005 (the Agreement) by and between Trubion Pharmaceuticals, Inc. (Trubion) and Wyeth, acting... (Filed With SEC on August 14, 2020)
- Collaboration and License Agreement, dated as of December 19, 2005, by and among Wyeth Pharmaceuticals and Trubion Pharmaceuticals, Inc (Filed With SEC on August 14, 2020)
- Amended and Restated Manufacturing Services Agreement, dated September 28, 2017, by and between Emergent BioSolutions Inc. and Aptevo Therapeutics Inc (Filed With SEC on March 13, 2018)
- Collaboration and Option Agreement, dated as of July 20, 2017, by and between Aptevo Research and Development LLC, and Alligator Bioscience AB (Filed With SEC on November 13, 2017)
- Amended and Restated COMMERCIAL SUPPLY AGREEMENT BETWEEN CMC ICOS BIOLOGICS, INC. and APTEVO BIOTHERAPEUTICS LLC. DISCLAIMER THIS DOCUMENT IS ISSUED BY CMC FOR DISCUSSION PURPOSES... (Filed With SEC on August 10, 2017)
- MANUFACTURING SERVICES AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016 TABLE OF CONTENTS (Filed With SEC on August 2, 2016)
